Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Glioblastoma 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Sarcoma 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Glioma 2Brain Neoplasms 2Atypical Squamous Cells of the Cervix 2Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Smoking Cessation 1Smoking 1Sexual Dysfunction, Physiological 1Pilonidal Sinus 1Peritoneal Neoplasms 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neurofibroma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Mouth Neoplasms 1Meningioma 1Melanoma 1

Interventions

lenvatinib 1fluorodopa F 18 1cabozantinib 1Thyroidectomy 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Restraint, Physical 1Radiofrequency Ablation 1Practice Guidelines as Topic 1Neck Dissection 1Magnetic Resonance Spectroscopy 1Laser Therapy 1High-Energy Shock Waves 1Gefitinib 1Ferrosoferric Oxide 1Decision Support Techniques 1Cryosurgery 1Cryoelectron Microscopy 1Absorptiometry, Photon 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Medullary × Restraint, Physical × Clear all
NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled
CNSEndocrine

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡